abstract |
The present application relates to non-human primate (NHP) induced pluripotent stem cell (IPSC)-derived hepatocytes and methods of producing the same. Additionally, the present application relates to methods for the use of NHP IPSC-derived hepatocytes in drug screening, drug safety assessment, and infection models. |